No abstract available
Plain language summary
This Viewpoint discusses therapeutic drug monitoring as a necessary treatment paradigm and the need for regulatory agencies to provide the conditions to make it happen.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Accidents, Traffic*
-
Drug Monitoring*
-
Humans
-
Models, Statistical